About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The research group in General Surgery aims to develop research activities in the field of Surgery from the most clinical and surgical aspects related to the quality of care to the most basic and translational aspects of etiopathogenesis, pathophysiology and the bases of the diseases included in its different areas of interest, as well as in the therapeutic procedures to address them. It is focused in several topics that include the fields of Abdominal Wall Surgery, biomaterials and bioengineering, Colorectal Surgery and Proctology, General Endocrine, Bariatric and Metabolic Surgery, Esophagogastric Surgery, and Thoracic Surgery. It includes clinical surgeons who make up the care teams of the various clinical lines and includes a basic research laboratory with two researchers with special interest in the study of the extracellular matrix and inflammation and biomaterials and their integration.
Research focus
The thoracic surgery research group is dedicated to provide the finest in clinical care, education and research in this surgery specialty to ultimately improve patients’ outcomes and quality of life. To this aim, technological improvements are combined with experimental and clinical research, with a special interest in lung transplantation
Sub-lines:
Clinical research
Humoral rejection in lung transplantation (Irene Bello Rodríguez, coordinator): To understand humoral forms of rejection in human lung transplantation to eventually develop therapies that extend long-term patients’ survival.
Experimental research
Air leakage prevention (Alberto Jáuregui Abularach, coordinator): To contribute to the design and evaluation of new patches and treatments used as a reinforcement or repair material in thoracic surgery, to eventually reduce lung air leakage and improve clinical outcomes. To this aim a new sheep-based surgically induced experimental model has been developed.
Thoracic sympathetic clipping (Javier Pérez Vélez, coordinator): Development of a swine model to perform clipping, unclipping and extirpation of different segments of the sympathetic chain.
Lung transplantation (Iker López Sánz, coordinator): Development of a rat model to perform lung transplantation for teaching and research purposes.
IP: -
IP: Josep A Villena Delgado Collaborators: Rosario Pardo Diaz, Andreea Ciudin Mihai, Marta Comas Martínez, Ramón Vilallonga Puy, Enzamaría Fidilio Meli Funding agency: Instituto de Salud Carlos III Funding: 248050 Reference: AC22/00023 Duration: 01/01/2023 - 31/12/2025
IP: Marc Martí Gallostra Collaborators: Elsa Garcia Moller, Eloy Espín Basany Funding agency: GETECCU Funding: 25000 Reference: GETECCU/PROJECTE/2022 Duration: 19/10/2022 - 01/09/2025
IP: Joaquin Balsells Valls Collaborators: Gianluca Pellino Funding agency: Asociación Española de Cirujanos Funding: 5000 Reference: AEC/BECA/2022/IBD/FERTILITY Duration: 18/10/2022 - 19/10/2025
IP: Maria Antonia Arbos Via Collaborators: Oscar González López, Amador Garcia Ruiz de Gordejuela, Manuel López Cano, Jose Luis Sánchez García, Iñigo Royo Crespo, Jordi Sabadell García, Laura Maria Romero Vielva, Ma Teresa Quiles Pérez, Francesc Vallribera Valls, Nivardo Rodríguez Conde, Marc Martí Gallostra, Manuel Armengol Carrasco, Eloy Espín Basany, Mireia Verdaguer Tremolosa, Sandra Castro Boix, Ramón Vilallonga Puy, Alberto Jauregui Abularach, Franco Marinello, Alejandro Solis Peña Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00210 Duration: 01/01/2022 - 30/06/2025
PhD student: Borja Villanueva Figueredo, Borja Villanueva Figueredo, Borja Villanueva Figueredo Director/s: Francesc Vallribera Valls, Francesc Vallribera Valls University: Universidad Autònoma de Barcelona Year: 2020
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
This pathology, common among patients who have undergone rectal resection due to cancer, causes alterations in bowel function with great impact on quality of life.
The research has received funding from the Spanish Society of Obesity Surgery and the Spanish Association of Surgeons.
